256 related articles for article (PubMed ID: 23908015)
1. The R740S mutation in the V-ATPase a3 subunit results in osteoclast apoptosis and defective early-stage autophagy.
Ochotny N; Voronov I; Owen C; Aubin JE; Manolson MF
J Cell Biochem; 2013 Dec; 114(12):2823-33. PubMed ID: 23908015
[TBL] [Abstract][Full Text] [Related]
2. The V-ATPase a3 subunit mutation R740S is dominant negative and results in osteopetrosis in mice.
Ochotny N; Flenniken AM; Owen C; Voronov I; Zirngibl RA; Osborne LR; Henderson JE; Adamson SL; Rossant J; Manolson MF; Aubin JE
J Bone Miner Res; 2011 Jul; 26(7):1484-93. PubMed ID: 21305608
[TBL] [Abstract][Full Text] [Related]
3. The R740S mutation in the V-ATPase a3 subunit increases lysosomal pH, impairs NFATc1 translocation, and decreases in vitro osteoclastogenesis.
Voronov I; Ochotny N; Jaumouillé V; Owen C; Manolson MF; Aubin JE
J Bone Miner Res; 2013 Jan; 28(1):108-18. PubMed ID: 22865292
[TBL] [Abstract][Full Text] [Related]
4. V-ATPase a3 isoform mutations identified in osteopetrosis patients abolish its expression and disrupt osteoclast function.
Matsumoto N; Matsukawa R; Takahashi S; Kudo K; Sun-Wada GH; Wada Y; Nakanishi-Matsui M
Exp Cell Res; 2020 Apr; 389(2):111901. PubMed ID: 32045577
[TBL] [Abstract][Full Text] [Related]
5. Vacuolar H+-ATPase d2 subunit: molecular characterization, developmental regulation, and localization to specialized proton pumps in kidney and bone.
Smith AN; Jouret F; Bord S; Borthwick KJ; Al-Lamki RS; Wagner CA; Ireland DC; Cormier-Daire V; Frattini A; Villa A; Kornak U; Devuyst O; Karet FE
J Am Soc Nephrol; 2005 May; 16(5):1245-56. PubMed ID: 15800125
[TBL] [Abstract][Full Text] [Related]
6. The mouse osteopetrotic grey-lethal mutation induces a defect in osteoclast maturation/function.
Rajapurohitam V; Chalhoub N; Benachenhou N; Neff L; Baron R; Vacher J
Bone; 2001 May; 28(5):513-23. PubMed ID: 11344051
[TBL] [Abstract][Full Text] [Related]
7. Genotype-phenotype relationship in human ATP6i-dependent autosomal recessive osteopetrosis.
Taranta A; Migliaccio S; Recchia I; Caniglia M; Luciani M; De Rossi G; Dionisi-Vici C; Pinto RM; Francalanci P; Boldrini R; Lanino E; Dini G; Morreale G; Ralston SH; Villa A; Vezzoni P; Del Principe D; Cassiani F; Palumbo G; Teti A
Am J Pathol; 2003 Jan; 162(1):57-68. PubMed ID: 12507890
[TBL] [Abstract][Full Text] [Related]
8. Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification.
Li YP; Chen W; Liang Y; Li E; Stashenko P
Nat Genet; 1999 Dec; 23(4):447-51. PubMed ID: 10581033
[TBL] [Abstract][Full Text] [Related]
9. Effects of human a3 and a4 mutations that result in osteopetrosis and distal renal tubular acidosis on yeast V-ATPase expression and activity.
Ochotny N; Van Vliet A; Chan N; Yao Y; Morel M; Kartner N; von Schroeder HP; Heersche JN; Manolson MF
J Biol Chem; 2006 Sep; 281(36):26102-11. PubMed ID: 16840787
[TBL] [Abstract][Full Text] [Related]
10. V-ATPases Containing a3 Subunit Play a Direct Role in Enamel Development in Mice.
Johnson L; Ganss B; Wang A; Zirngibl RA; Johnson DE; Owen C; Bradley G; Voronov I
J Cell Biochem; 2017 Oct; 118(10):3328-3340. PubMed ID: 28295540
[TBL] [Abstract][Full Text] [Related]
11. V-ATPase subunit ATP6AP1 (Ac45) regulates osteoclast differentiation, extracellular acidification, lysosomal trafficking, and protease exocytosis in osteoclast-mediated bone resorption.
Yang DQ; Feng S; Chen W; Zhao H; Paulson C; Li YP
J Bone Miner Res; 2012 Aug; 27(8):1695-707. PubMed ID: 22467241
[TBL] [Abstract][Full Text] [Related]
12. A rationale for osteoclast selectivity of inhibiting the lysosomal V-ATPase a3 isoform.
Nyman JK; Väänänen HK
Calcif Tissue Int; 2010 Sep; 87(3):273-83. PubMed ID: 20596699
[TBL] [Abstract][Full Text] [Related]
13. Atp6v1c1 is an essential component of the osteoclast proton pump and in F-actin ring formation in osteoclasts.
Feng S; Deng L; Chen W; Shao J; Xu G; Li YP
Biochem J; 2009 Jan; 417(1):195-203. PubMed ID: 18657050
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic terminus of vacuolar type proton pump accessory subunit Ac45 is required for proper interaction with V(0) domain subunits and efficient osteoclastic bone resorption.
Feng H; Cheng T; Pavlos NJ; Yip KH; Carrello A; Seeber R; Eidne K; Zheng MH; Xu J
J Biol Chem; 2008 May; 283(19):13194-204. PubMed ID: 18227071
[TBL] [Abstract][Full Text] [Related]
15. Murine ameloblasts are immunonegative for Tcirg1, the v-H-ATPase subunit essential for the osteoclast plasma proton pump.
Bronckers AL; Lyaruu DM; Bervoets TJ; Medina JF; DenBesten P; Richter J; Everts V
Bone; 2012 Apr; 50(4):901-8. PubMed ID: 22245629
[TBL] [Abstract][Full Text] [Related]
16. V-ATPases in osteoclasts: structure, function and potential inhibitors of bone resorption.
Qin A; Cheng TS; Pavlos NJ; Lin Z; Dai KR; Zheng MH
Int J Biochem Cell Biol; 2012 Sep; 44(9):1422-35. PubMed ID: 22652318
[TBL] [Abstract][Full Text] [Related]
17. Activity-independent targeting of mTOR to lysosomes in primary osteoclasts.
Wang A; Carraro-Lacroix LR; Owen C; Gao B; Corey PN; Tyrrell P; Brumell JH; Voronov I
Sci Rep; 2017 Jun; 7(1):3005. PubMed ID: 28592812
[TBL] [Abstract][Full Text] [Related]
18. Luteolin inhibition of V-ATPase a3-d2 interaction decreases osteoclast resorptive activity.
Crasto GJ; Kartner N; Yao Y; Li K; Bullock L; Datti A; Manolson MF
J Cell Biochem; 2013 Apr; 114(4):929-41. PubMed ID: 23129004
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the osteoclast V-ATPase by small interfering RNAs.
Hu Y; Nyman J; Muhonen P; Väänänen HK; Laitala-Leinonen T
FEBS Lett; 2005 Sep; 579(22):4937-42. PubMed ID: 16115623
[TBL] [Abstract][Full Text] [Related]
20. Novel c.G630A TCIRG1 mutation causes aberrant splicing resulting in an unusually mild form of autosomal recessive osteopetrosis.
Zirngibl RA; Wang A; Yao Y; Manolson MF; Krueger J; Dupuis L; Mendoza-Londono R; Voronov I
J Cell Biochem; 2019 Oct; 120(10):17180-17193. PubMed ID: 31111556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
